Clinical trial BI 1472-0001
A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation
| Organ | Multiple |
|---|---|
| Trial status | Trial closed for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/1b |
| Academic trial | Non |
| Sponsor | Boehringer Ingelheim |
| EudraCT Identifier | 2021-000460-29 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04973163 |
| Last update |